Cilostazol: all 123 studies that test it

Page 2 of 2. Open to participants first (22), then studies with results posted, then the rest; newest registration first within each.

• Cilostazol Versus Aspirin for Primary Prevention of Atherosclerotic EventsStatus unknownNCT00886574Phase 4
• To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting ConditionsCompletedNCT00881231Phase 1
• Cilostazol Verse Asprin for Vascular Dementia in Poststroke Patients With White Matter LesionsCompletedNCT00847860Phase 4
• Study of Cilostazol and Probucol Alone and in Combination on Atherosclerosis Related Biomarker---atherosclerosis Cerebral Infarction Patient as Study SubjectCompletedNCT00823875Phase 4
• Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related BiomarkerCompletedNCT00823849Phase 4
• The Efficacy of CILostazol ON Ischemic Complications After DES ImplantationCompletedNCT00776828Phase 4
• A Mono-center Study in Healthy Volunteers on the Comparative Bioavailability of Pletal 100 mg Tablets and a New Pletal 100 mg Orodispersible Tablet (ODT), This Latter in Fasting Conditions With and Without Water and Under Fed ConditionsCompletedNCT00773630Phase 1
• Cilostazol Stroke Prevention Study : A Placebo-controlled Double-blind Trial for Secondary Prevention of Cerebral Infarction.CompletedNCT00766545Phase 3
• Fasting Study of Cilostazol Tablets 100 mg and Pletal® Tablets 100 mgCompletedNCT00648388Phase 1
• The Comparison of Effects Between Increased Dose of Clopidogrel and Addition of CilostazolCompletedNCT00620646Not applicable
• Bioequivalency Study of 50 mg Cilostazol Tablets Under Fasting ConditionsCompletedNCT00602407Not applicable
• Bioequivalency Study of 100 mg Cilostazol Tablets Under Fasting ConditionsCompletedNCT00602173Not applicable
• Triple Versus Dual Antiplatelet Therapy After ABT578-Eluting StentCompletedNCT00589927Phase 4
• Effects of Cilostazol on Plasma Adipocytokine and Arterial StiffnessStatus unknownNCT00573950Phase 4
• Safety and Pharmacokinetics of Probucol and CilostazolCompletedNCT00549978Phase 4
• Effects of Cilostazol on VEGF and Oxidative Stress Biomarkers in Hemodialysis Patients With Peripheral Vascular DiseaseCompletedNCT00431249Phase 4
• Triple Versus Dual Antiplatelet Therapy in Patients Undergoing Coronary Stent ImplantationCompletedNCT00404716Phase 4
• The Use of Cilostazol in Patients With Diabetic NephropathyCompletedNCT00272831Phase 4
• Cilostazol in Acute Ischemic Stroke Treatment (CAIST)CompletedNCT00272454Phase 4
• Efficacy and Safety Study of Cilostazol to Prevent Reoccurrence of StrokeCompletedNCT00202020Phase 3
• Claudication: Exercise Versus Endoluminal Revascularization (CLEVER)Status unknownNCT00132743Phase 3
• Safety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's PhenomenonCompletedNCT00048776Phase 4
• Safety and Efficacy of Pletal(Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's PhenomenonCompletedNCT00048763Phase 4

← Cilostazol overview